#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus infection Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Glioblastoma Antiphospholipid syndrome Leiomyosarcoma B-cell small lymphocytic lymphoma recurrent Leukocyte adhesion deficiency type I Immunodeficiency Thrombocytopenia Transplant rejection Cholangiosarcoma Small cell lung cancer Ventricular fibrillation Ocular myasthenia Alveolar rhabdomyosarcoma More trials…

    Learn about Rare Diseases

    Haemophilia B without inhibitors Loeys-Dietz syndrome – Diagnostics Paroxysmal nocturnal haemoglobinuria – Basic Information Familial haemophagocytic lymphohistiocytosis – Basic Information Langerhans’ cell histiocytosis – Life with Disease Chronic granulomatous disease – Basic Information Progressive multifocal leukoencephalopathy – Diagnostics Ocular melanoma – Basic Information Marginal zone lymphoma refractory – Life with Disease Prader-Willi syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Diazepam NIZUBAGLUSTAT Gad20-209-Fsp-A4 Filgotinib Nadunolimab Indocyanine Green Palopegteriparatide ALKYLATING AGENTS Valganciclovir Hydrochloride A/(H3N2)-LIKE VIRUS ANTIGEN ZILUCOPLAN Azathioprine Mva-209-Fsp-B4 Polydextrose Paroxetine Hydrochloride Pevonedistat Erlotinib Stx-241 Rocatinlimab Valiltramiprosate More therapies…

    Learn about Your Condition

    Tympanic membrane perforation Insomnia Netherton's syndrome Diphtheria Dermatitis atopic Haemorrhage EGFR gene mutation Gastrointestinal disorder Candida infection Acute promyelocytic leukaemia Cardiogenic shock Gastric cancer stage IV Antisynthetase syndrome Mesothelioma malignant Aortic stenosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Zdravotnicke stredisko Dubina v.o.s.

Zdravotnicke stredisko Dubina v.o.s.

Lidmily Male 656, Studanka, Pardubice, 530 12, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Immune Response and Safety of a New Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Varicella
    Investigated Drugs:
    • GSKVX000000025896
    • VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED)
    • VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
    Belgium Czechia Estonia Poland

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!